PharmaCyte Biotech Inc（PMCB）價格預測

$0.501

-0.014 (-2.74%)收盤時

價格預測

1-Day Price Prediction

+1.83%

1-Week Prediction

+5.50%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

PMCB 相似圖表分析預測

Alphio's PMCB stock price prediction model matches the current PharmaCyte Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.50 (+1.83%). The 1-week path is $0.51 (+5.50%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 PharmaCyte Biotech Inc 股票嗎？

PharmaCyte Biotech Inc is not a good buy right now due to its declining performance and negative financial metrics. The current price is $0.515, and the stock has seen a 30.22% decline year-to-date. Additionally, the RSI is at 31.15, indicating that the stock is oversold, but this does not necessarily imply a buying opportunity given the overall negative trend.

PMCB 股價於 Monday 收在 $0.50，此前下跌 -2.74%

PharmaCyte Biotech Inc (PMCB) last closed at $0.4881, losing -2.56%. These facts feed the 1-day and 1-week PMCB price prediction above.

預測驅動因素

PharmaCyte Biotech Inc（PMCB）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 PMCB 最接近的股票，依相似度排序。

BALL

93.34%

-1.46%

TSCO

92.39%

+2.55%

CSGP

92.09%

-44.00%

NNE

91.70%

+24.79%

EXLS

91.59%

+11.34%

PMCB 季節性分析

Historically the probability of a positive September return for PMCB is 0.00%. January offers the highest probability of a positive month at 60.66%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…